Antimicrobial Susceptibility Testing Market Outlook 2030: Industry Insights & Opportunity Evaluation, 2019-2030

$5,000$10,000

Antimicrobial Susceptibility Testing Market to surpass USD 5.8 Billion by 2030 from USD 2.8 Billion in 2019 in terms of value growing at a CAGR of 6.25% throughout the forecast period, i.e., 2020-30.

Clear

Description

Antimicrobial Susceptibility Testing Market: Market Segments: By Product (Manual, Automated Laboratory Instruments, Culture and Growth Media and Consumables); By Type (Antibacterial, Antifungal, Antiparasitic and Others); By Application (Diagnostics, Drug Discovery and Development, Epidemiology and Others); By End User (Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Research &Academic Institutes and Clinical Research Organizations); and Region – Global Analysis by Market Size, Share & Trends for 2014 – 2020 and Forecasts to 2030
Product Overview
Antimicrobial susceptibility testing is a technique used to assess whether an antibiotic is susceptible to a single organism or group of organisms. The most frequently used research methods for the analysis of antimicrobial susceptibility are broth microdilution or rapid automated instrument methods. Such approaches are used and sold commercially with materials and equipment.
Market Highlights
Antimicrobial Susceptibility Testing Market is expected to project a notable CAGR of 6.25% in 2030.
Antimicrobial Susceptibility Testing Market to surpass USD 5.8 Billion by 2030 from USD 2.8 Billion in 2019 in terms of value growing at a CAGR of 6.25% throughout the forecast period, i.e., 2020-30. Factors such as growing global infectious disease incidences, increased funding and government initiatives, the emergence of multidrug resistance, and technological developments in the production of rapid AST techniques are expected to drive the growth of the global market for antimicrobial susceptibility testing in the coming years.
Antimicrobial Susceptibility Testing Market: Segments
Automated laboratory instruments segment to grow with the highest CAGR during 2020-30
Antimicrobial Susceptibility Testing Market is segmented by product as automated laboratory instruments, manual antimicrobial susceptibility testing products, culture and growth media, and consumables. Susceptibility testing discs, MIC strips, and susceptibility testing plates are used in manual antimicrobial susceptibility testing items.
Antimicrobial Susceptibility Testing Market: Market Dynamics
Drivers
Rising Use of Antimicrobial Susceptibility
Recent times have seen a marked change to personalized drugs, which is growing the market for goods to screen for antimicrobial susceptibility. Rising government policies are expected to complement the demand for antimicrobial susceptibility tests in diagnostic laboratories and hospitals in terms of improving quality healthcare infrastructure at a global level and increasing susceptibility to infectious diseases.
Restrain
Stringent Government Regulatory Policies
Strict government regulatory policies and the difficulties associated with testing for antimicrobial susceptibility are expected to hamper market growth over the forecast period. Automated research instruments for antimicrobial susceptibility are fitted with highly advanced features and functionalities and priced at premium rates.
Antimicrobial Susceptibility Testing Market: Key Players
• Accelerate Diagnostics Inc
Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence and SWOT Analysis
• ALIFAX Srl
• Becton, Dickinson and Co.
• bioMérieux SA
• Bio-Rad Laboratories Inc.
• Bruker Corp.
• Danaher Corp.
• Merck KGaA
• Scientific Digital Imaging Plc
• Thermo Fisher Scientific Inc
Antimicrobial Susceptibility Testing Market: Regions
Antimicrobial Susceptibility Testing Market is segmented based on regional analysis into five major regions. These include North America, Latin America, Europe, APAC and MENA.
Antimicrobial Susceptibility Testing Market in North America led the market with a lion share of more than XX.X% in 2019 owing to the increasing R&D to develop novel automated AST systems, the growing prevalence of infectious diseases, safety issues and technical developments in products susceptible to antimicrobials. In addition, most of the world’s leading corporations are headquartered in the area or have a strong presence in this market, and others have also concentrated on expanding to improve their scope and capabilities. This is another important factor attributed to the market’s significant growth. In addition, well-established precision medicine awareness campaigns and the use of antimicrobial testing drives, beneficial government initiatives, and an increase in the number of research collaborations are some of the factors that are expected to fuel market growth.
Antimicrobial Susceptibility Testing Market report also contains analysis on:
Antimicrobial Susceptibility Testing Market Segments:
By Product:
• Manual Antimicrobial Susceptibility Testing Products
o Susceptibility Testing Disks
o MIC Strips
o Susceptibility Testing Plates
• Automated Laboratory Instruments
• Culture and Growth Media
• Consumables
By Type:
• Antibacterial Testing
• Antifungal Testing
• Antiparasitic Testing
• Others
By Application:
• Diagnostics
• Drug Discovery and Development
• Epidemiology
• Others
By End-user:
• Hospitals and Diagnostic Centers
• Pharmaceutical and Biotechnology Companies
• Research &Academic Institutes
• Clinical Research Organizations (CROs)

• Antimicrobial Susceptibility Testing Market Dynamics
• Antimicrobial Susceptibility Testing Market Size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies Involved in the Market
• Value Chain of the Market
• Market Drivers and Restraints
FAQs on Antimicrobial Susceptibility Testing Market
· Which segment is anticipated to hold the largest market share?
· At what CAGR is the market anticipated to grow between 2020 and 2030?
· Who are the key players in the Antimicrobial Susceptibility Testing Market?
· What could be the challenging factors in the growth of Antimicrobial Susceptibility Testing Market?
· What are the growth drivers for the Antimicrobial Susceptibility Testing Market?

Additional information

Publisher

Geography Covered

Date Published

,

Pages

Format

Table of Contents

Contents
1. Executive Summary
2. Antimicrobial Susceptibility Testing Market
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3. Research Methodology
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4. Average Pricing Analysis
5. Macro-Economic Indicators
6. Market Dynamics
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends
7. Correlation & Regression Analysis
7.1. Correlation Matrix
7.2. Regression Matrix
8. Recent Development, Policies & Regulatory Landscape
9. Risk Analysis
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis
10. Antimicrobial Susceptibility Testing Analysis
10.1. Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological
11. Antimicrobial Susceptibility Testing Market
11.1. Market Size & forecast, 2019A-2030F
11.1.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
11.1.2. By Volume (Million Units) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12. Antimicrobial Susceptibility Testing: Market Segmentation
12.1. By Regions
12.1.1. North America:
• By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.2. Europe:
• By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.3. Asia-Pacific:
• By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.4. MEA:
• By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.5. Latin America:
• By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2. By Product: Market Share (2020-2030F)
12.2.1. Manual Antimicrobial Susceptibility Testing Products, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.2. Automated Laboratory Instruments, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.3. Culture and Growth Media, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.4. Consumables, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.3 By Type: Market Share (2020-2030F)
12.3.1. Antibacterial Testing, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.3.2. Antifungal Testing, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.3.3. Antiparasitic Testing, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.3.4. Others, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.4. By Application: Market Share (2020-2030F)
12.4.1. Diagnostics, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.4.2. Drug Discovery and Development, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.3. Epidemiology, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.4.4. Others, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.5. By End User: Market Share (2020-2030F)
12.5.1. Hospitals and Diagnostic Centers, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.5.2. Pharmaceutical and Biotechnology Companies, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.5.3. Research &Academic Institutes, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.5.4. Clinical Research Organizations (CROs), By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
13. Company Profile
13.1.1. Bio-Rad Laboratories, Inc
13.1.2. Company Overview
13.1.3. Company Total Revenue (Financials)
13.1.4. Market Potential
13.1.5. Global Presence
13.1.6. Key Performance Indicators
13.1.7. SWOT Analysis
13.1.8. Product Launch
13.2. Alifax
13.3. Becton Dickinson, and Company
13.4. Creative Diagnostics
13.5. Resistell AG
13.6. Danaher Corporation
13.7. Thermo Fisher Scientific Inc
13.8. Merck KGaA

14 Consultant Recommendation
**The above given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.

RSS
Follow by Email